Clinical Trial Update: Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating nivolumab in combination with ipilimumab for previously untreated metastatic uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Uveal Melanoma | Phase 2 | Status: COMPLETED